Frequency and Contributing Factors of Obstructive Sleep Apnea in Individuals with Pneumoconiosis: A Cross-Sectional Analysis - Takeaways - MDSpire

Frequency and Contributing Factors of Obstructive Sleep Apnea in Individuals with Pneumoconiosis: A Cross-Sectional Analysis

  • By

  • Yanmei Cao

  • Yiming Zhao

  • Liangbin Xie

  • Jie Liu

  • Yulin Kong

  • Xinyu Jiang

  • Xin Zhou

  • Mi Zhou

  • Yuwen Chen

  • Yuan Xu

  • Xiaolin Liu

  • Chunyan Min

  • Rui Chen

  • February 27, 2026

  • 0 min

Share

  • 1

    Pneumoconiosis is a prevalent occupational disease in China, resulting from prolonged exposure to industrial mineral dust.

  • 2

    Obstructive sleep apnea (OSA) affects 2% to 4% of adults and is linked to serious health consequences, including chronic hypoxemia.

  • 3

    The prevalence of OSA in patients with interstitial lung disease (ILD) ranges from 28% to 69%, highlighting a significant comorbidity.

  • 4

    Pneumoconiosis increases the risk of OSA due to structural and functional changes in the respiratory system.

  • 5

    This study enrolled 217 patients with pneumoconiosis to assess the prevalence and factors associated with OSA.

Original Source(s)

Frequency and Contributing Factors of Obstructive Sleep Apnea in Individuals with Pneumoconiosis: A Cross-Sectional Analysis

  • by Yanmei Cao, Yiming Zhao, Liangbin Xie, Jie Liu, Yulin Kong, Xinyu Jiang, Xin Zhou, Mi Zhou, Yuwen Chen, Yuan Xu, Xiaolin Liu, Chunyan Min, Rui Chen

  • February 27, 2026

Related Content

Not All Lung Bacteria Are the Enemy

Cross-disease meta-analysis also found modest associations with lung function, though findings varied by disease type

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.